Please Wait
Applying Filters...
menu
    • menu
    AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

    Stock Recap
    #PipelineProspector

    Menu

    (3S)-3-(aminomethyl)-5-methylhexanoic acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 106Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    24/02/2025 TAPI Technology & API Services
    Israel
    		 TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL R1-CEP 2017-165 - Rev 00 Pregabalin 2023-07-18 Valid Chemical 2777
    24/02/2025 TAPI Technology & API Services
    Israel
    		 TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL CEP 2020-375 - Rev 02 Pregabalin, ID 3636/9111 2024-02-08 Valid Chemical 2777